true, but you dont base the success of your product on currency issues, either way! the currency issue will not go away for quite some time. its more that the product sales are stagnant. one would think with that many new partners there should be an increase of sales. but its not happending! why?
whats interesting from the CC is that Chan wants to get EAP for Sepsis and not for Cytokine removal only. but IMO he has no hard data for sepsis so this could turn out to be a risky play, we will see end of September or beginning of october. for me there is no reason to jump in right now. im watching from the side line.
ALL IMO & GLTYA
SABAI
News 
Market Data 
Discover 
